The Discounted Cash Flow (DCF) valuation of E-Therapeutics PLC (ETX.L) is (45.70) GBP. With the latest stock price at 9.00 GBP, the upside of E-Therapeutics PLC based on DCF is -607.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 8.7% | 7.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (116.35) - (27.84) | (45.70) |
| Upside | -1392.8% - -409.3% | -607.7% |